Immunization with the major surface glycoprotein of Pneumocystis carinii elicits a protective response

Vaccine

Volumn 16, Issue 11-12, 1998, Pages 1149-1157

  Theus, Sue A ^a   George Smulian, A ^a   Steele, Paul ^b   Linke, Michael J ^a   Walzer, Peter D ^a  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

AIDS; Opportunistic infection; Pneumonia

Indexed keywords

CORTICOSTEROID; GLYCOPROTEIN; PNEUMOCYSTIS CARINII VACCINE; UNCLASSIFIED DRUG;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMORAL IMMUNITY; IMMUNE DEFICIENCY; IMMUNIZATION; MALE; NONHUMAN; OPPORTUNISTIC INFECTION; PNEUMOCYSTIS CARINII; PNEUMOCYSTOSIS; PRIORITY JOURNAL; RAT; SCORING SYSTEM; SURVIVAL;

EID: 0031802282     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(98)80113-8     Document Type: Article

References (33)

1. Davey, R.T. and Masur, H. Recent advances in the diagnosis, treatment, and prevention of Pneumocystis carinii pneumonia. Antimicrob. Agents Chemother. 1990, 34, 499-504.
2. Keely, S.P., Stringer, J.R. and Baughman, P.P. et al. Genetic variation among Pneumocystis carinii hominis isolates in recurrent pneumocystosis. J. Infect. Dis. 1995, 172, 595-598.
3. Hughes, W.T., Kim, H.Y., Price, R.A. and Miller, C. Attempts at prophylaxis for murine Pneumocystis carinii pneumonitis. Curr. Ther. Res. 1973, 15, 581-588.
4. Harmsen, A.G., Chen, W. and Gigliotti, F. Active immunity to Pneumocystis carinii reinfection in T-cell-depleted mice. Infect. Immun. 1995, 63, 2391-2395.
5. Gigliotti, F. and Harmsen, A.G. Pneumocystis cariniil host origin defines the antibody specificity and protective response induced by immunization. J. Infect. Dis. 1997, 176, 1322-1326.
6. Kovacs, J.A., Powell, F. and Edman, J.C. et al. Multiple genes encode the major surface glycoprotein of Pneumocysits carinii. J. Biol. Chem. 1993, 268, 6034-6040.
7. Linke, M.J., Smulian, A.G., Stringer, J.R. and Walzer, P.D. Characterization of multiple unique cDNAs encoding the major surface glycoprotein of rat-derived Pneumocystis carinii. Parasitol. Res. 1994, 80, 478-482.
8. Sunkin, S.M., Stringer, S.L. and Stringer, J.R. A tandem repeat of rat-derived Pneumocystis carinii genes encoding the major surface glycoprotein. J. Euk. Microbiol. 1994, 41, 292-300.
9. Wada, M., Sunkin, S., Stringer, J.R. and Nakamura, Y. Antigenic variation by positional control of major surface glycoportein gene expression in Pneumocystis carinii. J. Infect. Dis. 1995, 171, 1563-1569.
10. Graves, D.C., McNabb, S.J., Worley, M.A., Downs, T.D. and Ivey, M.H. Analysis of rat Pneumocystis carinii antigens recognized by human and rat antibodies by using Western blotting. Infect. Immun. 1986, 54, 96-103.
11. Walzer, P.D., Stamforth, D., Linke, M.J. and Cushion, M.T. Pneumocystis carinii: immunoblotting and immunofluorescent analysis of serum antibodies during experimental rat infection and recovery. Exp. Parasitol. 1987, 63, 319-328.
12. Theus, S.A., Linke, M.J., Andrews, R.P. and Walzer, P.D. Proliferative and cytokine responses to a major surface glycoprotein of Pneumocysits carinii. Infect. Immun. 1993, 61, 4703-4709.
13. Theus, S.A., Sawhney, N., Smulian, A.G. and Walzer, P.D. Proliferation and cytokine response of human T lymphocytes isolated from HIV patients to the major surface glycoprotein of Pneumocystis carinii. J. Infect. Dis. (in press). Author, any update?
14. Pottratz, ST., Paulsrud, J., Smith, J.S. and Martin, W.J. Pneumocystis carinii attachment to cultured lung cells by Pneumocystis gp120, a fibronectin binding protein. J. Clin. Invest. 1991, 88, 403-407.
15. Gigliotti, F. and Hughes, W.T. Passive immunoprophylaxis with specific monoclonal antibody confers partial protection against Pneumocystis carinii pneumonitis in animal models. J. Clin. Invest. 1988, 81, 1666-1668.
16. Theus, S.A., Andrews, R.P., Steele, P. and Walzer, P.D. Adoptive transfer of lymphocytes sensitized to the major surface glycoprotein of Pneumocystis carinii confers protection in the rat. J. Clin. Invest. 1995, 95, 2587-2593.
17. Smulian, A.G., Stringer, J.R., Linke, M.J. and Walzer, P.D. Isolation and characterization of a recombinant antigen of Pneumocystis carinii. Infect. Immun. 1992, 60, 907-915.
18. Lundgren, B., Lipchik, G.Y. and Kovacs, J.A. Purification and characterization of a major human Pneumocystis carinii surface antigen. J. Clin. Invest. 1991, 87, 163-170.
19. Linke, M.J., Sunkin, S.M., Andrews, R.P., Stringer, J.R. and Walzer, P.D. The expression, structure, and location of epitopes of the major surface glycoprotein of Pneumocystis carinii f. sp. carinii. Clin. Diag. Lab. Immunol. (in press). Author, any update?
20. Theus, S.A., Andrews, R.P., Linke, M.J. and Walzer, P.D. Characterization of rat CD4 T cell clones specific for the major surface glycoprotein of Pneumocystis carinii. J. Euk. Microbiol. 1997, 44, 96-100.
21. Theus, S.A., Smulian, A.G., Sullivan, D.W. and Walzer, P.D. Cytokine responses to the native and a recombinant form of the major surface glycoprotein of Pneumocystis carinii. Clin. Expt. Immunol. 1997, 109, 255-260.
22. Kim, C.K., Foy, J.M. and Cushion, M.T. et al. Comparison of histological and quantitative techniques in evaluation of therapy for experimental Pneumocystis carinii pneumonia. Antimicrob. Agents Chemother. 1987, 31, 197-201.
23. Walzer, P.D., Kim, C.K., Foy, J.M., Linke, M.J. and Cushion, M.T. Inhibitors of folic acid synthesis in the treatment of experimental Pneumocystis carinii pneumonia. Antimicrob. Agents Chemother. 1988, 32, 96-103.
24. Walzer, P.D., Kim, C.K., Foy, J.M. and Zhang, J. Furazolidone and nitrofurantoin in the treatment of experimental Pneumocystis carinii pneumonia. Antimicrob. Agents Chemother. 1991, 35, 158-163.
25. Walzer, P.D., Foy, J.M. and Steele, P. et al. Activities of antifolate, antiviral, and other drugs in an immunosuppressed rat model of Pneumocystis carinii pneumonia. Antimicrob. Agents Chemother. 1992, 36, 1935-1942.
26. Walzer, P.D., Foy, J.M., Steele, P. and White, M. Synergistic combinations of Ro 11-8958 and other dihydrofolate reductase inhibitors with sulfamethoxazole and dapsone for therapy of experimental pneumocystosis. Antimicrob. Agents Chemother. 1993, 37, 1436-1443.
27. Bartlett, M.S., Edlind, T.D. and Lee, C.H. et al. Albendazole inhibits Pneumocystis carinii proliferation in inoculated immunosuppressed mice. Antimicrob. Agents Chemother. 1994, 38, 1834-1837.
28. Bartlett, M.S., Queener, S.F., Shaw, M.M., Richardson, J.D. and Smith, J.W. Pneumocystis carinii is resistant to imidazole antifungal agents. Antimicrob. Agents Chemother. 1994, 38, 1859-1861.
29. Powrie, F. and Coffman, R.L. Cytokine regulation of T cell function: Potential for therapeutic intervention. Immunol. Today 1993, 14, 270-274.
30. Mocci, S. and Coffman, R.L. Induction of a Th2 population from a polarized Leishmania-specific Th1 population by in vitro culture with IL-4. J. Immunol. 1995, 154, 3779-3787.
31. Tonnetti, L, Spaccapelo, R. and Cenci, E. et al. Interleukin-4 and -10 exacerbate candidiasis in mice. Eur. J. Immunol. 1995, 25, 1559-1565.
32. Esolen, L.M., Fasano, M.B. and Flynn, J. Pneumocystis carinii osteomyelitis in a patient with common variable immunodeficiency. N. Engl. J. Med. 1992, 326, 999-1001.
33. Sidman, C.L., and Roths, J.B. New Animal Models for Pneumocystis carinii research: immunodeficient mice. In Walzer, PD ed. Pneumocystis carinii Pneumonia. New York: Marcel Dekker, Inc., 1994, 223-236.